JW Pharma
Scope
Date
~
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Medicine
JW Pharm exports new antibiotic substance to US
JW Pharmaceutical Co. has become the first South Korean drug maker to develop the generic version of a next-generation antibiotic substance, the med...
Jun 10, 2021 (Gmt+09:00)
-
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
Bio
Korea rises as production hub for coronavirus treatments; darling of global pharmas
South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...
Sep 15, 2020 (Gmt+09:00)
Latest News
- 1 NPS-backed new prime office struggles with poor demand
- 2 Affinity-backed SSG.COM offers first voluntary redundancy
- 3 Lotte to cut basic chemicals in portfolios for profitability
- 4 Young rich Koreans: Financially literate, self-directing
- 5 LG Elec logs record Q2 profit on home appliances, car parts